CVE-2020-3412

Cisco Webex Meetings Scheduled Meeting Template Creation Vulnerability

Description

A vulnerability in the scheduled meeting template feature of Cisco Webex Meetings could allow an authenticated, remote attacker to create a scheduled meeting template that would belong to another user in their organization. The vulnerability is due to insufficient authorization enforcement for the creation of scheduled meeting templates. An attacker could exploit this vulnerability by sending a crafted request to the Webex Meetings interface to create a scheduled meeting template. A successful exploit could allow the attacker to create a scheduled meeting template that would belong to a user other than themselves.

Categories

4.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.13%
Vendor Advisory cisco.com
Affected: Cisco Cisco Webex Meetings
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-3412?
CVE-2020-3412 has been scored as a medium severity vulnerability.
How to fix CVE-2020-3412?
To fix CVE-2020-3412, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-3412 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-3412 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-3412?
CVE-2020-3412 affects Cisco Cisco Webex Meetings.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.